Cancer cell plasticity represents the basis for cancer progression. Let’s think about the ability of cancer cells to grow within different niches: these cells are so adaptable that are able to grow in their original tissue, as well as in metastatic sites, even if histologically very different. Similarly, they can adapt to adverse stimuli, [...]
About Giulia PiaggioThis author has not yet filled in any details.
So far Giulia Piaggio has created 90 blog entries.
React4life will participate in the JRC Summer School 2021: Non-Animal Approaches in Science – The Three R… evolutionGiulia Piaggio2021-03-17T19:01:52+00:00
Our CEO, Maurizio Aiello will partecipate as speaker at the 2021 edition of the JRC Virtual Summer School on Non-animal Approaches in Science organised by the European Commission's Joint Research Centre (JRC) and its EU Reference Laboratory for alternatives to animal testing (EURL ECVAM), while our Biomedical engineer Ilaria Pulsoni will partecipate as attendee. To further [...]
She has been with us for just over a year. She is head of internal and external communication of the company and the marketing activities. Today we present Giulia, our brand manager. Giulia, it seems like yesterday that we started working together but a year has already passed. We speak your language: can you [...]
The development of new research methods for drug analysis represents one of the most significant aspects of drug development. However, this complicated process still faces some challenges from significant issues such as time consumption, low-throughput, poor reliability and standardization, high cost. The traditional 2D static culture in most cases do not predict the in [...]
“My passion has always been to do something that would generate a concrete and immediate impact on the society”.Giulia Piaggio2021-01-12T08:10:18+00:00
Interview with Future and Emerging Technologies Innovator Silvia Scaglione from the Eruopean Commission website https://ec.europa.eu/digital-single-market/en/news/interview-future-and-emerging-technologies-innovator-silvia-scaglione which we thanks. Silvia Scaglione is specialist in bioengineering. Since 2010, she is a permanent researcher at the Italian National Research Council (CNR) and head of the Labor atory of Tissue Engineering CNR-IEIIT in Genoa. She is also founder, [...]
She joined the finance team in November. Two months are passed and we asked her some questions which she answered with a hint of shyness. We present Fabiana, our accountant. 1) Fabiana, first of all, welcome on board! Tell us about yourself. Thanks! I am a quiet person, but at the same time pro-active. [...]
“Femininity without compromise. Innovation is never conventional”, the editorial project that involved our founder Silvia Scaglione.Giulia Piaggio2020-11-30T09:33:38+00:00
"Innovation is never conventional". It is with this slogan that Pasqua Vini, a historic Veronese winery specializing in the production of quality Venetian and Italian wines, has built a project to pay homage to 33 innovative women who have changed the rules of the game in the world of innovation. Among these 33 women [...]
The challenge of the cosmetics industry: discovering compounds that block pollutants in contact with the skin.Giulia Piaggio2020-11-18T11:15:23+00:00
Scientific research shows that polluting particles are extremely fine and highly dangerous. Our test allows to quantify the percentage of particulate passes through the skin model to determine the protective factor of the cosmetic compound. We call it "antipollution test": it is fast, innovative and effective. Air pollution can cause serious health problems, especially [...]
Reducing the time and cost of screening for new compounds and limiting the number of animals used in in-vivo tests is the future of drug discovery. Gallery
Reducing the time and cost of screening for new compounds and limiting the number of animals used in in-vivo tests is the future of drug discovery.
Reducing the time and cost of screening for new compounds and limiting the number of animals used in in-vivo tests is the future of drug discovery.Giulia Piaggio2020-10-16T09:48:53+00:00
Cristina Degrassi, CEO of MTTLab, tells us about her experience with React4life which led to the publication of the paper on Altex: "3D fluid-dynamic ovarian cancer model resembling systemic drug administration for efficacy assay". The ability to control drugs quickly and efficiently with a more accurate preclinical tumor model is of great importance in [...]